SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trillium Therapeutics
TRIL 20.36+2.0%Nov 26 2:56 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Miljenko Zuanic who wrote (137)1/4/2018 4:51:13 PM
From: Bladerunner17  Read Replies (2) of 294
 
I thought the data presented at ASH were pretty good. I thought the Market reaction was unwarranted. I think they could partner at any time. With a market cap under $130 million and enough cash for, at least, another full year, I think this is not a bad time to buy. Furthermore, we may be starting to see the beginning of a strong bull market in small and micro-cap biotech. Just look at ITEK, ADXS, CCXI, ARQL, VYGR, TOCA, ITCI, AUPH, BLCM, JNCE, just to mention some that I follow. I'm sure there are many others.

Bladerunner
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News